Research Presentation Sessions: Oncologic Imaging

RPS 1816 - Advances in MRI for oncological imaging

Lectures

1

Response evaluation of cancer therapeutics (RESPECT-MI) in metastatic breast cancer (MBC): preliminary data from a whole body magnetic resonance imaging (WB-MRI) study

07:00Roberta Maggioni, Veduggio Con Colzano / IT

2

$MRI proton density fat fraction for estimation of tumour grade in steatotic hepatocellular carcinoma$

MRI proton density fat fraction for estimation of tumour grade in steatotic hepatocellular carcinoma

07:00Darius Kurt, Bonn / DE

3

Impact of 18F-FDG PET/MRI on therapeutic management of women with newly diagnosed breast cancer: results from double-center trial

07:00Julian Kirchner, Dusseldorf / DE

4

The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma

07:00Jin Wang, Guangzhou / CN

5

Clinical impact of whole-body MRI as a problem solving tool in patients with high risk colorectal cancer

07:00Doenja Marina Johanna Lambregts, Amsterdam / NL

6

Diffusion-weighted MRI after radiofrequency ablation for hepatocellular carcinoma

07:00Heba Albalshy, shebin el-kom / EG

7

ADC measurement in whole body MRI for multiple myeloma: a three b-values vs. two b-values DWI comparison

07:00Marta Zerunian, Rome / IT

8

$Is bone marrow fat fraction a surrogate of marrow cellularity? A quantitative whole spine T2 Dixon study$

Is bone marrow fat fraction a surrogate of marrow cellularity? A quantitative whole spine T2 Dixon study

07:00Charbel Mourad, Beyrouth / LB

9

EMVI detection in locally advanced rectal cancer after pCRT with T2, DWI and contrast-enhanced sequences: a comparison

07:00Raimondo Angelone, Padua / IT

10

Correlation between MRI, surgical and pathological peritoneal cancer index for colorectal cancer patients undergoing cytoreductive surgery and HIPEC